公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2012 | The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture-recapture analysis | WAN-TING HUANG ; Huang W.-I.; Huang Y.-W.; Hsu C.-W.; Chuang J.-H. | Vaccine | 29 | ||
2019 | Risk of cutaneous adverse reactions associated with allopurinol or febuxostat in real-world patients: A nationwide study | Lin C.-W.; Huang W.-I.; Chao P.-H.; Chen W.-W.; FEI-YUAN HSIAO | International Journal of Clinical Practice | 17 | 15 | |
2018 | Temporal trends and patterns in carbamazepine use, related severe cutaneous adverse reactions, and HLA-B*15:02 screening: A nationwide study | Lin C.-W.; Huang W.-I.; Chao P.-H.; Chen W.-W.; FEI-YUAN HSIAO | Epilepsia | 23 | 22 | |
2020 | Using real-world evidence for pharmacovigilance and drug safety-related decision making by a resource-limited health authority: 10 years of experience in Taiwan | Chen W.-W.; Lin C.-W.; Huang W.-I.; Chao P.-H.; Gau C.-S.; FEI-YUAN HSIAO | Pharmacoepidemiology and Drug Safety | 2 | 2 |